Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $32.12 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 01/21/15 All times are local (Market data is delayed by at least 15 minutes).

victrex plc (VTXPF) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/18/14 - $31.76
52 Week Low
10/23/14 - $25.45
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VICTREX PLC (VTXPF)

Related News

No related news articles were found.

victrex plc (VTXPF) Related Businessweek News

No Related Businessweek News Found

victrex plc (VTXPF) Details

Victrex plc, together with its subsidiaries, manufactures and sells polymers worldwide. It operates through two business units, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymers; APTIV films; VICTREX pipes for use in harsh environments; VICOTE coatings; and biomaterial solutions for use in various applications, such as spine, arthroscopy, dental, trauma, and knee for the surgical and medical device markets. It primarily serves automotive, aerospace, energy and industrial, electronics, and medical markets. The company was incorporated in 1993 and is based in Thornton Cleveleys, the United Kingdom.

701 Employees
Last Reported Date: 12/8/14
Founded in 1993

victrex plc (VTXPF) Top Compensated Officers

Chief Executive Officer, Executive Director, ...
Total Annual Compensation: 710.8K GBP
Group Finance Director, Executive Director an...
Total Annual Compensation: 343.4K GBP
Managing Director of Victrex Polymer Solution...
Total Annual Compensation: 425.8K GBP
Compensation as of Fiscal Year 2014.

victrex plc (VTXPF) Key Developments

Victrex plc Appoints Martin Court as Executive Director, Effective from April 1, 2015

The Board of Victrex plc announced the appointment of Dr. Martin Court as an Executive Director, effective from April 1, 2015. Martin, who joined Victrex in February 2013, is Managing Director of Invibio, Victrex's medical business.

Victrex plc to Report Q1, 2015 Interim Management Statement on Feb 04, 2015

Victrex plc announced that they will report Q1, 2015 interim management statement on Feb 04, 2015

Victrex plc Reports Interim Management Statement Results for the First Quarter of 2015

Victrex plc reported interim management statement results for the first quarter of 2015. For the period, the company's group revenue of £59.8 million was 14% ahead of the prior year against of £52.4 million for the same period a year ago. The Group sales volume of 967 tonnes 42% ahead of the prior year against of 679 tonnes in previous year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VTXPF:US $32.12 USD 0.00

VTXPF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VTXPF.
View Industry Companies

Industry Analysis


Industry Average

Valuation VTXPF Industry Range
Price/Earnings 18.6x
Price/Sales 5.9x
Price/Book 4.2x
Price/Cash Flow 18.6x
TEV/Sales 5.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VICTREX PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at